![Bryan Dunnivant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Dunnivant
Directeur/Membre du Conseil chez
Intradigm Corp.
Profil
Mr. Bryan Dunnivant, CFA MBA, is Managing Director & Oxford Investment Fellow at Oxford Financial Group Ltd.
Prior to joining Oxford in 2015, he was Investment Director, Pension and Benefits, at Eli Lilly and Company.
In that role he had investment management and oversight responsibility for approximately $13 billion in assets.
His responsibilities included due diligence, manager selection and monitoring, performance evaluation and risk management.
He has over 25 years of leadership experience in the United States and Europe.
He holds a BS in Chemical Engineering from the University of Illinois.
He also holds an MBA from Butler University.
He is a CFA charter holder.
Postes actifs de Bryan Dunnivant
| Sociétés | Poste | Début |
|---|---|---|
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Directeur/Membre du Conseil | 01/01/2008 |
Anciens postes connus de Bryan Dunnivant
| Sociétés | Poste | Fin |
|---|---|---|
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Président | 28/07/2010 |
| ELI LILLY AND COMPANY | Directeur des opérations | 31/12/2004 |
| PROTAGONIST THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Fast Track Systems, Inc.
 Fast Track Systems, Inc. Packaged SoftwareTechnology Services Provides clinical trial software and professional services to pharmaceutical and biotechnology companies | Directeur/Membre du Conseil | - |
Formation de Bryan Dunnivant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Fast Track Systems, Inc.
Fast Track Systems, Inc. Packaged SoftwareTechnology Services Provides clinical trial software and professional services to pharmaceutical and biotechnology companies | Technology Services |
Butler University
 Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures invests in companies located in the European regions and North America, primarily in the United States. The firm target companies operating in the fields of life sciences, biotechnology, medical technology and healthcare information technology sectors. It provides financing for early stage capital requirements. | Finance |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
